Disclosure

University of Florida College of Medicine

Conflict of Interest Disclosure

2021 Inova Cherry Blossom Cardiovascular Symposium

It is the policy of the University of Florida College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all programs it provides. In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, the University of Florida College of Medicine is required to disclose to the activity audience the relevant financial relationships of all persons involved in the selection, development, and presentation of CME content. Persons who refuse or fail to disclose conflicts of interest are disqualified from participating in the CME activity.

All conflicts of interest have been resolved prior to the educational activity through one of the following mechanisms:

  • altering the financial relationship with the commercial interest
  • altering the individual’s control over CME content about the products or services of the commercial interest
  • validating the activity content through independent peer review.

Relevant financial relationships appear below.

The following speakers and planning committee members have an affiliation/financial interest in the following areas:

  • William Abraham, MD – Consultant: Impulse Dynamics, Vectorious Medical Technologies, V-Wave Medical
  • Brett Atwater, MD – Grant/Research Support: Abbott Medical, Boston Scientific; Consultant: Abbott Medical, Biosense Webster, Medtronic, Biotronik; Speakers Bureau: Medtronic
  • Wayne Batchelor, MD, MHS – Grant/Research Support: Boston Scientific, Abbott; Consultant: Idorsia, Medtronic, Boston Scientific, Abbott, V Wave; Speakers Bureau: Abbott, Medtronic, Abiomed
  • James Daubert, MD – Grant/Research Support: Medtronic; Consultant: Abbott, Biosense, Biotronik, Boston Scientific, Microport, Farapulse, Medtronic and Vytronus
  • Stephen Gaeta, MD, PhD – Consultant: Biosense Webster
  • Nadim Geloo, MD – Speakers Bureau: Medtronic; Stock Shareholder: Medtronic, Boston Scientific, Abbott
  • Nasrien Ibrahim, MD – Consultant: Cytokinetics, Novartis; Other Financial or Material Support (Honoraria): Medtronic, Roche
  • Vineet Kumar, MD – Consultant: Medtronic
  • JoAnn Lindenfeld, MD – Grant/Research Support: AstraZeneca, Volumetrix, Sensible Medical; Consultant: AstraZeneca, Boehringer Ingelheim, Boston Scientific, CVRx, Edards Lifesciences, Impulse Dynamics, VWave
  • Darren McGuire, MD, MHSc – Grant/Research Support: Boehringer Ingelheim, Sanofi, AstraZeneca, Merck & Co, Pfizer, Novo Nordisk, Esperion, Lilly USA, Lexicon, CSL Behring; Consultant: Lilly USA, Boehringer Ingelheim, Merck & Co, Novo Nordisk, Applied Therapeutics, Metavant, Sanofi, Afimmune, Lexicon
  • Alan Miller, MD – Grant/Research Support: Merck; Consultant: Abbott, Boehringer Ingelheim, Pfizer, CVRx, and Respicardia
  • Ann Marie Navar, MD, PhD – Grant/Research Support: Amgen, Janssen, Amarin, Sanofi, Regeneron, and BMS; Consultant: Amarin, Amgen, Astra Zeneca, BI, Esperion, Janssen, Lilly, Sanofi, Regeneron, NovoNordisk, Novartis, The Medicines Company, New Amsterdam, Cerner, 89Bio, and Pfizer
  • Christopher O’Connor, MD, MACC, FESC, FHFSA, FHFA – Grant/Research Support: Merck (VICTORIA Biomarker Sub-Study); Consultant: Bayer, Bristol Myers Squibb Foundation, Dey, L.P. (Merck), and Abiomed
  • Sean Pokorney, MD, MBA – Grant/Research Support: Pfizer, Bristol-Myers Squibb, Janssen Pharmaceutical, Boston Scientific; Consultant: Pfizer, Bristol-Myers Squibb, Janssen Pharmaceutical, Boston Scientific, Medtronic; Speakers Bureau: Zoll, Boston Scientific, Philips
  • Marc Sabatine, MD, MPH – Grant/Research Support: Amgen; Anthos Therapeutics, Inc.; AstraZeneca; Daiichi-Sankyo; Eisai; Intarcia; Medicines Company; MedImmune; Merck; Novartis; Pfizer; Consultant: Althera; Amgen; Anthos Therapeutics; AstraZeneca; Intarcia; Merck; Other: Member of the TIMI Study Group, which has also received institutional research grant support through Brigham and Women’s Hospital from: Abbott, Regeneron, Roche, and Zora Biosciences
  • Matthew Sherwood, MD, MHS – Grant/Research Support: Boston Scientific; Consultant: Medtronic
  • Scott Solomon, MD – Grant/Research Support: Actelion, Alnylam, Amgen, AstraZeneca, Bellerophon, Bayer, BMS, Celladon, Cytokinetics, Eidos, Gilead, GSK, Ionis, Lilly,  Lone Star Heart, Mesoblast, MyoKardia, NIH/NHLBI, Neurotronik, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Theracos; Consultant: Abbott, Actelion, Akros, Alnylam, Amgen, Arena, AstraZeneca, Bayer, Boeringer-Ingelheim, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi-Sankyo,  Gilead, GSK, Ironwood, Lilly,  Merck, Myokardia,  Novartis, Roche, Takeda, Theracos, Quantum Genetics
  • Marc Wish, MD – Consultant: Medtronic

The following speakers and planning committee members have no relevant financial relationships to disclose:

  • Aysha Arshad, MD
  • Christopher deFilippi, MD
  • Kelly Epps-Anderson, MD, MSHP
  • Mona Fiuzat, PharmD
  • Larry Jackson II, MD, MHs
  • Spencer King, MD
  • Mitchell Psotka, MD, PhD
  • Haroon Rashid, MD
  • Eric Sarin, MD
  • John Spertus, MD, MPH, FACC, FAHA
  • Hamid Taheri, MD
  • Henry Tran, MD
  • Elizabeth Wilson
  • Shawn Yazdani, MD

No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/.